Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-040983
Filing Date
2021-06-16
Accepted
2021-06-16 17:15:55
Documents
2
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1528
2 POA DOCUMENT poa.txt EX-24.3_993314 3119
  Complete submission text file 0001209191-21-040983.txt   6054
Mailing Address C/O ENTASIS THERAPEUTICS HOLDINGS INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address
Behanna Heather (Reporting) CIK: 0001751873 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40288 | Film No.: 211022338

Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Issuer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations